Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sangita Malhotra"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
We describe our experience with intravenous amoxicillin-clavulanate, which is new to the Canadian market. The majority of patients were successfully de-escalated from piperacillin-tazobactam or a carbapenem for respiratory infections or skin and soft
Externí odkaz:
https://doaj.org/article/5db97c7c4fef4b5285b1996caa50cb34
Publikováno v:
American Journal of Health-System Pharmacy. 78:2209-2215
Purpose A case of osteomyelitis caused by multidrug-resistant (MDR) Pseudomonas aeruginosa is reported. Summary An 84-year-old Caucasian male with an underlying history of type 2 diabetes, peripheral vascular disease, and coronary artery disease had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f859a68e34929c44eaf5ec2094023e20
https://doi.org/10.1093/ajhp/zxab294
https://doi.org/10.1093/ajhp/zxab294
Autor:
Sangita Malhotra, Lucy Shen, Elena Vikis, Shawn MacKenzie, Kenneth G. Atkinson, Suzan Abu-Abed, George Melich, David Youssef
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Gastrointestinal cytomegalovirus infections can occur in immunocompetent patients. • Diagnosis relies on histopathologic examination of endoscopic biopsy specimen. • Early recognition and antiviral treatment are important to patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64c04589660fd5a8c45b66720241967
Publikováno v:
Open Forum Infectious Diseases
Background Intravenous (IV) vancomycin is commonly used to treat MRSA (methicillin-resistant Staphylococcus aureus) infections and is typically dosed at 15 mg/kg every 12 hours. Pharmacokinetic studies, animal models, and limited human study suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53be2cfda05c3c1613bac9829e9dd8b
https://doi.org/10.1093/ofid/ofx163.805
https://doi.org/10.1093/ofid/ofx163.805
A mutation in Mycobacterium tuberculosis rpoB gene confers rifampin resistance in three HIV-TB cases
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 90(2)
Rifampin is a key component of standard short-course first-line therapy against Mycobacterium tuberculosis (MTB). Rifampin monoresistant MTB, previously a rare phenomenon, is now being reported at increasing rates worldwide. We report a mutation in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d82a039d3e1ec27a7046306aa30cccc
https://pubmed.ncbi.nlm.nih.gov/20097612
https://pubmed.ncbi.nlm.nih.gov/20097612